Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Telbivudine and Lamivudine Use in Highly Viremic Mothers to Prevent Hepatitis B Transmission

NCT01743079 is registered in ClinicalTrials.gov with Beijing YouAn Hospital as lead sponsor.

NCT NCT01743079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01743079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Telbivudine and Lamivudine Use in Highly Viremic Mothers to Prevent Hepatitis B Transmission
Lead sponsor
Beijing YouAn Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2009
Completion date
July 31, 2013
Enrollment
700 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, complication, late pregnancy, transmission